R&D Podcasts | pharmaphorum

Podcasts

R&D

pharmaphorum podcast Episode 209a, Gene Mack

Allosteric small molecule therapies in PD, with Gene Mack

pharmaphorum looks back to a conversation with Gain Therapeutics' CEO Gene Mack earlier in the year, on research in the Parkinson's disease space.

R&D

pharmaphorum podcast Episode 207a, Brandon Pence

The importance of being disruption ready, with Brandon Pence

Brandon Pence, recently appointed President and COO of Fujifilm Biosciences, discusses the cell culture media industry and being disruption ready.

R&D

pharmaphorum podcast Episode 203a: Ali Pashazadeh, Treehill

The glimmer of opportunity behind the storm: Ali Pashazadeh ...

Former surgeon and investment banker Ali Pashazadeh, CEO of Treehill, discusses the current ‘perfect storm’ in biotech.

R&D

pharmaphorum podcast Episode 202a - Hilary Eaton, Profluent

Changing the drug development treatment paradigm: Hilary Eat...

Hilary Eaton, a rare disease advocate and chief business officer at Profluent, discusses AI-first protein design and accelerating biomedicine.

R&D

pharmaphorum podcast Episode 201a - Adityo Prakash, Verseon

Increasing trial efficiency: Adityo Prakash talks small data...

Adityo Prakash, founder and CEO of Verseon, discusses small datasets, real-world scenarios, and organoids.

R&D

Immune mediation, B-cell depletion, and female leadership – ...

In a new pharmaphorum podcast, Aoife Brennan, CEO of Climb Bio, discusses the treatment of immune-mediated diseases.